Increased number and function of natural killer cells in human immunodeficiency virus 1‐positive subjects co‐infected with herpes simplex virus 2
暂无分享,去创建一个
D. Nixon | L. Lanier | J. M. Chapman | J. Barbour | M. M. Sauer | E. Ho | K. Carvalho | B. Long | E. Kallas | B. Vu | Ann E. Erickson
[1] J. Baeten,et al. Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. , 2008, The Journal of infectious diseases.
[2] Jun O. Liu,et al. The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation* , 2008, Journal of Biological Chemistry.
[3] Scott Rose,et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[4] D. Nixon,et al. Conferral of Enhanced Natural Killer Cell Function by KIR3DS1 in Early Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[5] D. Nixon,et al. HIV-1/HSV-2 Co-Infected Adults in Early HIV-1 Infection Have Elevated CD4+ T Cell Counts , 2007, PloS one.
[6] A. Ashkar,et al. Adaptive immune responses fail to provide protection against genital HSV‐2 infection in the absence of IL‐15 , 2007, European journal of immunology.
[7] M. Altfeld,et al. Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells1 , 2007, The Journal of Immunology.
[8] Amalio Telenti,et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1 , 2007, Nature Genetics.
[9] M. Diamond,et al. Herpesvirus latency confers symbiotic protection from bacterial infection , 2007, Nature.
[10] E. Rosenberg,et al. Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. , 2007, The Journal of infectious diseases.
[11] Vincent Foulongne,et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. , 2007, The New England journal of medicine.
[12] D. Nixon,et al. Cutting Edge: KIR3DS1, a Gene Implicated in Resistance to Progression to AIDS, Encodes a DAP12-Associated Receptor Expressed on NK Cells That Triggers NK Cell Activation1 , 2007, The Journal of Immunology.
[13] M. Altfeld,et al. NK cell function in HIV-1 infection. , 2006, Current molecular medicine.
[14] A. Wald,et al. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] A. Angulo,et al. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. , 2006, Blood.
[16] Richard J Hayes,et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies , 2006, AIDS.
[17] Hendrik Streeck,et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. , 2005, Blood.
[18] Rachel E. Owen,et al. Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections , 2005, Journal of Virology.
[19] A. Fauci,et al. Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[20] E. Kallás,et al. Establishment of the serologic testing algorithm for recent human immunodeficiency virus (HIV) seroconversion (STARHS) strategy in the city of São Paulo, Brazil. , 2004, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.
[21] Jessica M Malenfant,et al. CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.
[22] Jessica M Malenfant,et al. Increased Natural Killer Cell Activity in Viremic HIV-1 Infection1 , 2004, The Journal of Immunology.
[23] É. Oksenhendler,et al. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. , 2004, Journal of Clinical Virology.
[24] T. Quinn,et al. The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics , 2004, Journal of acquired immune deficiency syndromes.
[25] M. Daucher,et al. Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] A. Ashkar,et al. Interleukin-15 and Natural Killer and NKT Cells Play a Critical Role in Innate Protection against Genital Herpes Simplex Virus Type 2 Infection , 2003, Journal of Virology.
[27] T. Chun,et al. Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. , 2003, The Journal of infectious diseases.
[28] Patty W. Wright,et al. A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] J. Zeh,et al. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression. , 2002, The Journal of infectious diseases.
[30] Keith Hoots,et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS , 2002, Nature Genetics.
[31] J. Zeh,et al. Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. , 1998, The Journal of infectious diseases.
[32] B. Pedersen,et al. Clinical Progression of HIV Infection: Role of NK Cells , 1997, Scandinavian journal of immunology.
[33] J L Sullivan,et al. Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.
[34] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[35] C. López,et al. Natural Killing of Herpes Simplex Virus Type 1-Infected Target Cells: Normal Human Responses and Influence of Antiviral Antibody , 1979, Infection and immunity.
[36] D. Nixon,et al. Immune reconstitution of CD56(dim) NK cells in individuals with primary HIV-1 infection treated with interleukin-2. , 2008, The Journal of infectious diseases.
[37] S. Yong,et al. Human Cytomegalovirus Infection Induces a Rapid and Sustained Change in the Expression of NK Cell Receptors on CD8 T Cells , 2008 .
[38] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[39] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.